New Institute Leadership and Executive Director
Effective October 1, Elena Sacharow took over the role of managing director and institute director from Dr. Annette Burchardt. As a pharmacist, Ms. Sacharow brings many years of experience in …
InphA News
Future Day 2026
At this year’s nationwide Career Day on April 23, we once again welcomed curious and motivated students to our facility. Our trainees came up with some great experiments and talked …
InphA celebrates 30th anniversary
On December 1, 1995, the AMI Arzneimitteluntersuchungsinstitut-Nord GmbH began its operations on Emil-Sommer-Straße in Bremen. On January 16, 2013, the company was renamed InphA GmbH, marking a strategic realignment of …
OMCL Network Annual Meeting
Active participation in the 28th Annual Meeting of the European Network of Official Medicines Control Laboratories from 5 to 9 June in Madrid. The event is hosted by the European …
Participation of InphA at WHO Conference
InphA participated in the WHO Conference “Consultation on Quality Control and Pharmaceutical Specifications of Medicines” from 25 – 27 April in Geneva.Dr. Frank Höper presented laboratory results from the verifications …
Future Day at InphA
Future Day 2023 at InphA! On 27.04.2023, seven pupils were able to get an idea of the training profession of a chemical laboratory assistant. Certainly not an everyday occurrence and …
InphA celebrates its 25th anniversary
On 1 December 1995, the former AMI Arzneimitteluntersuchungsinstitut-Nord GmbH began operations in Emil-Sommer-Straße in Bremen. On 16 January 2013, the company was renamed InphA GmbH and the institute underwent a …
Training of staff from African drug regulatory authorities
As part of the Global Health Protection Programme (GHPP) of the Federal Ministry of Health, InphA GmbH has been training staff from quality control laboratories of African drug regulatory authorities …
Cooperation with the WHO to modernise the International Pharmacopoeia
InphA GmbH is conducting a project in cooperation with the World Health Organisation (WHO) to revise monographs of the International Pharmacopoeia. The International Pharmacopoeia is a collection of regulations for …